The Supreme Court has ruled that isolated human genes are not patentable. But what does that mean for gene-related technologies, like diagnostic assays, and the use of biomarkers? What has the Court said about the patentability of software? The Supreme Court has ruled on these and other patent issues recently, and the U.S. Patent Office has responded with some guidelines for inventors seeking to obtain patent protection in these technology areas. To learn about these recent Court decisions and Patent Office guidelines, please join us for an update and discussion on these patent topics.
Date: September 18, 2014
Please RSVP to Tinieka Thrailkill at email@example.com or (901) 448-7827.
For more information or questions about the seminar, please contact Dr. Lakita Cavin at Lcavin@uthsc.edu or (901) 448-7825.